Skip to main content

Table 3 VWF: Ag and NLR in relation to stroke risk factors among patients

From: New stroke prognostic factors

Items

VWFAg mean ± SD

t test

P value

NLR < 2 (n = 25) No (%)

NLR ≥ 2 (n = 35) No (%)

Test (χ2)

P value

Smoking

11.01 ± 2.22

  

11 (44.0)

8 (22.9)

3.01

0.083

No

10.85 ± 2.56

0.23

0.819

14 (56.0)

17 (77.1)

  

Hypertension

11.63 ± 2.43

  

13 (52.0)

12 (34.3)

  

No

10.38 ± 2.33

2.01

0.049*

12 (48.0)

23 (65.7

1.88

0.170

DM

11.01 ± 2.23

  

1 (4.0)

19 (54.3)

  

No DM

10.84 ± 2.56

0.24

0.813

24 (96.0)

16 (45.7)

16.59

< 0.001*

Hyper cholesterolemia

12.02 ± 2.40

  

6 (24.0)

20 (57.1)

  

No

10.04 ± 2.12

3.37

0.001*

19 (76.0)

15 (42.9)

6.52

0.011*

AF

8.51 ± 1.75

  

5 (20.0)

3 (8.6)

  

No AF

11.27 ± 2.33

3.20

0.002*

20 (80.0)

32 (91.4)

1.65

0.199

Carotid stenosis

12.05 ± 2.15

  

3 (12.0)

12 (34.3)

  

No

10.52 ± 2.43

2.17

0.034*

22 (88.0)

23 (65.7)

3.86

0.049*

Combined risk

12.88 ± 1.93

  

1 (4.0)

5 (14.3)

  

No

10.68 ± 2.40

2.17

0.034*

24 (96.0

30 (85.7)

1.71

0.190

Blood group O

11.45 ± 2.42

  

12 (48.0)

21 (60.0)

  

Non-O

10.23 ± 2.32

1.98

0.052*

13 (52.0)

14 (40.0

0.85

0.357

Hyperurecemia

10.63 ± 2.08

  

3 (12.0)

5 (14.0)

  

No

10.94 ± 2.50

0.34

0.736

22 (88.0)

30 (86.0)

0.07

0.797

VWF:Ag Mean ± SD

   

10.66 ± 2.47

11.07 ± 2.44

t = 0.65

0.250

BMI (≥ 25)

12.18 ± 2.1410.26 ± 2.34

3.08

0.003*

6 (24.0)

14 (40.0)

1.68

0.195

Normal

   

19 (76.0)

21 (60.0)

  
  1. *Means highly significant